Overview
Tatja Hirvikoski practices in Stockholm, Sweden. Hirvikoski is rated as a Distinguished expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Their top areas of expertise are Attention Deficit Hyperactivity Disorder (ADHD), Congenital Adrenal Hyperplasia (CAH), Autism Spectrum Disorder, and Intersex.
Their clinical research consists of co-authoring 69 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 22 articles in the study of Attention Deficit Hyperactivity Disorder (ADHD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Attention Deficit Hyperactivity Disorder (ADHD)
- Advanced
- Autism Spectrum DisorderHirvikoski isAdvanced. Learn about Autism Spectrum Disorder.
- Congenital Adrenal Hyperplasia (CAH)
- IntersexHirvikoski isAdvanced. Learn about Intersex.
- Experienced
- Chronic PainHirvikoski isExperienced. Learn about Chronic Pain.